BUZZ-Street View: Uncertainty around Hims' GLP-1 business still weighs

Reuters02-24 20:50

BUZZ-Street View: Uncertainty around Hims' GLP-1 business still weighs

** Hims & Hers Health's HIMS.N shares slide 7.4% to $14.40 premarket

** Telehealth firm on Monday forecast first-quarter revenue below estimates, as it faces regulatory scrutiny over its weight-loss business and invests heavily in international expansion

** At least 5 brokerages cut stock's PT

GLP-1 UNCERTAINTY WEIGHS ON FORECAST

** BofA Securities ("underperform," PO: $12.5) says "GLP-1 franchise is rapidly eroding and the core business is dealing with competitive pressures that point to revenue for 2026"

** Leerink Partners ("market perform," PT: $17.5) says there is "significant uncertainty around the GLP-1 franchise with a number of unresolved matters still swirling" and warns they "can't be confident" in the forecast with "another shoe to drop on the GLP‑1 side"

** Citi ("sell/high risk," PT: $13.25) says HIMS' annual forecast leaves key GLP-1 questions unanswered and requires "heavy back-half lift"; warns ongoing GLP‑1 uncertainty makes it hard for co to hit even low end of its revenue forecast

** Needham ("hold") says HIMS' FY26 forecast was "disappointing" as weight-loss legal and regulatory uncertainty persists

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2613190647?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-24 20:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2613190647","market":"nz","top_or_hot":-1,"title":"BUZZ-Street View: Uncertainty around Hims' GLP-1 business still weighs","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Street View: Uncertainty around Hims' GLP-1 business still weighs</title></head><body><p>** Hims &amp; Hers Health's <span>HIMS.N</span> shares slide 7.4% to $14.40 premarket</p><p>** Telehealth firm on Monday <span>forecast</span> first-quarter revenue below estimates, as it faces <span>regulatory scrutiny</span> over its weight-loss business and invests heavily in international expansion</p><p>** At least 5 brokerages cut stock's PT</p><p>GLP-1 UNCERTAINTY WEIGHS ON FORECAST </p><p>** BofA Securities (\"underperform,\" PO: $12.5) says \"GLP-1 franchise is rapidly eroding and the core business is dealing with competitive pressures that point to revenue for 2026\"</p><p>** Leerink Partners (\"market perform,\" PT: $17.5) says there is \"significant uncertainty around the GLP-1 franchise with a number of unresolved matters still swirling\" and warns they \"can't be confident\" in the forecast with \"another shoe to drop on the GLP‑1 side\"</p><p>** Citi (\"sell/high risk,\" PT: $13.25) says HIMS' annual forecast leaves key GLP-1 questions unanswered and requires \"heavy back-half lift\"; warns ongoing GLP‑1 uncertainty makes it hard for co to hit even low end of its revenue forecast</p><p>** Needham (\"hold\") says HIMS' FY26 forecast was \"disappointing\" as weight-loss legal and regulatory uncertainty persists</p><p> (Reporting by Kamal Choudhury in Bengaluru)</p><p> ((Kamal.Choudhury@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Street View: Uncertainty around Hims' GLP-1 business still weighs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Street View: Uncertainty around Hims' GLP-1 business still weighs\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-24 20:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Street View: Uncertainty around Hims' GLP-1 business still weighs</title></head><body><p>** Hims &amp; Hers Health's <span>HIMS.N</span> shares slide 7.4% to $14.40 premarket</p><p>** Telehealth firm on Monday <span>forecast</span> first-quarter revenue below estimates, as it faces <span>regulatory scrutiny</span> over its weight-loss business and invests heavily in international expansion</p><p>** At least 5 brokerages cut stock's PT</p><p>GLP-1 UNCERTAINTY WEIGHS ON FORECAST </p><p>** BofA Securities (\"underperform,\" PO: $12.5) says \"GLP-1 franchise is rapidly eroding and the core business is dealing with competitive pressures that point to revenue for 2026\"</p><p>** Leerink Partners (\"market perform,\" PT: $17.5) says there is \"significant uncertainty around the GLP-1 franchise with a number of unresolved matters still swirling\" and warns they \"can't be confident\" in the forecast with \"another shoe to drop on the GLP‑1 side\"</p><p>** Citi (\"sell/high risk,\" PT: $13.25) says HIMS' annual forecast leaves key GLP-1 questions unanswered and requires \"heavy back-half lift\"; warns ongoing GLP‑1 uncertainty makes it hard for co to hit even low end of its revenue forecast</p><p>** Needham (\"hold\") says HIMS' FY26 forecast was \"disappointing\" as weight-loss legal and regulatory uncertainty persists</p><p> (Reporting by Kamal Choudhury in Bengaluru)</p><p> ((Kamal.Choudhury@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4196","symbol_name":"保健护理服务","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL4N3ZK13Z:1","article_id":"2613190647","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2613190647","pubTimestamp":1771937446,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Street View: Uncertainty around Hims' GLP-1 business still weighs** Hims & Hers Health's HIMS.N shares slide 7.4% to $14.40 premarket** Telehealth firm on Monday forecast first-quarter revenue below estimates, as it faces regulatory scrutiny over its weight-loss business and invests heavily in international expansion** At least 5 brokerages cut stock's PTGLP-1 UNCERTAINTY WEIGHS ON FORECAST ** BofA Securities  says \"GLP-1 franchise is rapidly eroding and the core business is dealing with competitive pressures that point to revenue for 2026\"** Leerink Partners  says there is \"significant uncertainty around the GLP-1 franchise with a number of unresolved matters still swirling\" and warns they \"can't be confident\" in the forecast with \"another shoe to drop on the GLP1 side\"** Citi  says HIMS' annual forecast leaves key GLP-1 questions unanswered and requires \"heavy back-half lift\"; warns ongoing GLP1 uncertainty makes it hard for co to hit even low end of its revenue forecast** Needh","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4196":"保健护理服务","HIMS":"Hims & Hers Health Inc.","HIYY":"YieldMax HIMS Option Income Strategy ETF","HIMY":"Defiance Leveraged Long + Income HIMS ETF","HMYY":"GraniteShares YieldBoost HIMS ETF","HIMZ":"DEFIANCE DAILY TARGET 2X LONG HIMS ETF"},"translate_title":"BUZZ街景：Hims GLP-1业务的不确定性仍然存在","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HIYY":0.6,"HIMS":1.97,"HIMY":0.6,"HMYY":0.6,"HIMZ":0.6},"content_text":"BUZZ-Street View: Uncertainty around Hims' GLP-1 business still weighs** Hims & Hers Health's HIMS.N shares slide 7.4% to $14.40 premarket** Telehealth firm on Monday forecast first-quarter revenue below estimates, as it faces regulatory scrutiny over its weight-loss business and invests heavily in international expansion** At least 5 brokerages cut stock's PTGLP-1 UNCERTAINTY WEIGHS ON FORECAST ** BofA Securities (\"underperform,\" PO: $12.5) says \"GLP-1 franchise is rapidly eroding and the core business is dealing with competitive pressures that point to revenue for 2026\"** Leerink Partners (\"market perform,\" PT: $17.5) says there is \"significant uncertainty around the GLP-1 franchise with a number of unresolved matters still swirling\" and warns they \"can't be confident\" in the forecast with \"another shoe to drop on the GLP‑1 side\"** Citi (\"sell/high risk,\" PT: $13.25) says HIMS' annual forecast leaves key GLP-1 questions unanswered and requires \"heavy back-half lift\"; warns ongoing GLP‑1 uncertainty makes it hard for co to hit even low end of its revenue forecast** Needham (\"hold\") says HIMS' FY26 forecast was \"disappointing\" as weight-loss legal and regulatory uncertainty persists (Reporting by Kamal Choudhury in Bengaluru) ((Kamal.Choudhury@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2613190647","isCrawlerRequest":true}